Skip to main content

Table 1 Characteristics of the study population

From: Clinical foot measurements as a proxy for plantar pressure testing in people with diabetes

 

Total population (n = 136)

Age (years)

68.4 (11.5)

Male (n (%))

71 (52.2%)

BMI (kg/m2)

32.7 (6.3)

Type 2 diabetes (n %)

123 (90.4%)

Duration of diabetes (years)

14.6 (11.1)

HbA1c (n = 104)

7.2 (1.2)

Insulin therapy alone or combination (n (%))

35 (25.7%)

Oral hypoglycaemics alone or in combination with insulin (n (%))

100 (73.5%)

Diet-controlled diabetes (n (%))

18 (13.2%)

Hypertension (n (%))

98 (72.1%)

Cardiovascular disease (n (%))

36 (26.5%)

History of DFU (n (%))

5 (3.7%)

Monofilament neuropathy (LOPS) (n (%))

43 (31.6%)

LOPS with foot deformity (n (%))

16 (11.8%)

Lunge equinus (n (%))

42 (31%)

Hallux limitus (n (%))

38 (28%)

Hallux abductus valgus score > 2 (n (%))

27 (20%)

Toe deformities > = 1 (n (%))

29 (21%)

Barefoot forefoot peak pressure (kPa)

687.6 (291.5)

In-shoe forefoot peak pressure (kPa)

234.1 (52.1)

  1. Values are mean (standard deviation) unless stated otherwise stated; BMI body mass index, HbA1c glycated haemoglobin